Symposium registration fee is as per the following:
| SAPH 2016 | SAPH 2016 | |
|---|---|---|
| Before 1 December 2015 | After 1 December 2015 | |
| Physicians | US$ 150 | US$ 200 |
| Fellows, nurses & paramedics | US$ 75 | US$ 100 |
| Pharmaceutical Staff | US$ 100 | USS 150 |
Dr Saleh Aldammas
Congress Chair
aldammas@hotmail.com
Saph.pht@gmail.com
Dr Abdulla Aldalaan
Congress Co-chair
aldalaan@hotmail.com
Saph.pht@gmail.com
Dr Hussam Sakkijha
Head, Executive committee
sakkijhahussamm@gmail.com
Saph.pht@gmail.com
Dr Hazem Hassan
Organizing Manager
hazem@globalaccess-eg.com
The Saudi Association for Pulmonary Hypertension (SAPH) is a medical and research national group of many medical specialists, who shared a common interest in the field of pulmonary vascular disease.
Dr. Butrous is a professor of cardiopulmonary sciences at the University of Kent, Canterbury, UK. His major research interest in PVD is in the field of management of pulmonary vascular diseases, pulmonary vascular disease secondary to infectious diseases, signaling mechanisms, and remodeling of pulmonary vasculature. He is the secretary general of the pulmonary vascular research institute (PVRI).
Professor Ghofrani is a senior physician at the University of Giessen lung center. He is the head of the divisions of pulmonary hypertension and intensive internal medicine. Dr. Ghofrani has developed new treatment concepts for patients with various disorders of pulmonary circulation. In 2002, Dr. Ghofrani was the recipient of the travel award of the ATS and the Francois Brenot Prize of the European Respiratory Society.
Paul M. Hassoun, MD, chairs the Assembly on Pulmonary Circulation, which consists of basic scientists and clinicians interested in the understanding of the vascular basis of lung disease—from the level of cell and molecular biology to translational biology and clinical medicine.